Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant To Retrain Staff In Response To FDA Inspection

This article was originally published in The Gray Sheet

Executive Summary

Guidant will retrain internal quality systems auditors at all of its cardiac rhythm management device manufacturing sites, including in Puerto Rico and Ireland, the company says in its response to a Form 483 issued by FDA last month
Advertisement

Related Content

Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested
Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested
Guidant Posts CRM Performance Data As Stakeholders Discuss Recall Notices
Guidant Posts CRM Performance Data As Stakeholders Discuss Recall Notices
Advertisement
UsernamePublicRestriction

Register

MT022841

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel